Compound 9

M3-selective positive allosteric modulator

oral bioavailability in rodent

from HTS and optimization

Bioorg. Med. Chem. Apr. 23, 2020

Astellas Pharma, Tsukuba, JP

“Compound 9” is the first potent M3-selective positive allosteric modulator, with potential utility as a biological tool compound. It does have secondary activity against M5 at high doses though. It’s…

 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.